- Type of Event: A virtual group meeting / group of investors meeting.
- Date and Time: The event is scheduled for Tuesday, September 22, 2026, at 11:00 A.M. IST onwards.
- Purpose: The officials of the Company will be interacting with a few investors/analysts. The discussion would be based on the general business outlook and information which is already in the public domain.
- UPSI Statement: The company explicitly states that during the meeting, no unpublished price sensitive information (UPSI) shall be disclosed.
- Management Participants: The specific officials participating are not named in the disclosure.
- Availability of Materials: The disclosure does not mention that a presentation, transcript, or recording will be made available.
Additional Notes Section
- This intimation is a compliance filing made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- The disclosure explicitly states that no financial data or specific performance figures are included in this announcement.
- The schedule of the meeting is noted as being subject to change due to exigencies.
- A copy of this disclosure is available on the company's website at https://www.molbiodiagnostics.com.
The document is signed by Darshan Raghunath Karekar, Company Secretary & Compliance Officer (Membership No: F13569).